Skip to main content Accessibility help
×
Home

The Cost of Antibiotic Resistance: Effect of Resistance Among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on Length of Hospital Stay

  • The Brooklyn Antibiotic Resistance Task Force

Abstract

To assess the effect of antimicrobial resistance on length of hospital stay, a case–control study compared infections due to four nosocomial pathogens. Significantly increased lengths of stay were associated with infections due to methicillin-resistant Staphylococcus aureus, extended-spectrum β-lactamase–producing Klebsiella pneumoniae, and carbapenem-resistant Acinetobacter baumannii or Pseudomonas aeruginosa. Infections with resistant pathogens are associated with prolonged hospitalization.

Copyright

References

Hide All
1.Altman, LK. Experts see need to control antibiotics and hospital infections. New York Times March 12, 1998; section A, p 12.
2.Saurina, G, Quale, JM, Manikal, VM, Oydna, E, Landman, D. Antimicrobial-resistant Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000;45:895898.
3.Manikal, VM, Landman, D, Saurina, G, Oydna, E, Lal, H, Quale, J. Endemic carbapenem-resistant Acinetobacter-sp. in Brooklyn, NY: citywide prevalence, inter-institutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101106.
4.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.
5.Wakefield, DS, Helms, CM, Mori, M, Pfaller, M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185192.
6.Saravolatz, LD, Markowitz, N, Arking, L, Pohlod, D, Fisher, E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:1116.
7.Boyce, JM, Landry, M, Deetz, TR, DuPont, HL. Epidemiologic studies of an outbreak of methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110116.
8.Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methi-cillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408411.
9.Lautenbauch, E, Patel, JB, Bilker, WB, Edelstein, PH, Fishman, NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:11621171.
10.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infection. Med Care 1987;25:481488.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed